Refining the Diagnosis and Prognostic Categorization of Acute Myeloid Leukemia Patients with an Integrated Use of Cytogenetic and Molecular Studies
暂无分享,去创建一个
J. Esteve | E. Campo | D. Colomer | D. Costa | M. Rozman | M. Díaz-Beyá | M. Torrebadell | Amparo Arias | Cándida Gómez | M. Pratcorona | C. Muñoz | A. Carrió | Anna Vidal | Daniela Berneaga
[1] R. Hills,et al. Independent prognostic variables in acute myeloid leukaemia. , 2011, Blood reviews.
[2] R. Hills,et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.
[3] Bob Löwenberg,et al. Review Articles (434 articles) , 2008 .
[4] L. Shaffer,et al. ISCN 2009 - An International System for Human Cytogenetic Nomenclature , 2009 .
[5] C. Schiffer. Molecular characterization of AML: a significant advance or just another prognostic factor? , 2008, Best practice & research. Clinical haematology.
[6] A. Hagemeijer,et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] K. Döhner,et al. Molecular characterization of acute myeloid leukemia , 2008, Haematologica.
[8] T. Haferlach,et al. Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients. , 2008, Blood.
[9] C. Preudhomme,et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature , 2008, Leukemia.
[10] M. Caligiuri,et al. FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications. , 2008, Blood.
[11] T. Haferlach. Molecular genetic pathways as therapeutic targets in acute myeloid leukemia. , 2008, Hematology. American Society of Hematology. Education Program.
[12] J. Licht,et al. Molecular characterization of acute myeloid leukemia and its impact on treatment , 2007, Current opinion in oncology.
[13] M. E. King,et al. Recent developments in acute myelogenous leukemia therapy. , 2007, The oncologist.
[14] A. Mead,et al. FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia. , 2007, Blood.
[15] C. Bloomfield,et al. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review , 2007, British journal of haematology.
[16] Brunangelo Falini,et al. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. , 2007, Blood.
[17] C. Bloomfield,et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? , 2007, Blood.
[18] C. Bloomfield,et al. A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies , 2006, Leukemia.
[19] Gerhard Ehninger,et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). , 2006, Blood.
[20] Gerhard Ehninger,et al. Prevalence and prognostic impact of NPM 1 mutations in 1485 adult patients with acute myeloid leukemia ( AML ) , 2006 .
[21] Jean McGowan-Jordan,et al. ISCN 2013 : an international system for human cytogenetic nomenclature (2013) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature , 2005 .
[22] Stefan Fröhling,et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. , 2005, Blood.
[23] J. Cayuela,et al. Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype. , 2005, Blood.
[24] Paola Fazi,et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. , 2005, The New England journal of medicine.
[25] S. Fröhling,et al. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia. , 2005, Haematologica.
[26] S. Fröhling,et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] H. Cavé,et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program , 2003, Leukemia.
[28] M. Caligiuri,et al. BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study. , 2003, Blood.
[29] D. Linch,et al. Flt3 mutations and leukaemia , 2003, British journal of haematology.
[30] Axel Benner,et al. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. , 2002, Blood.
[31] S. Fröhling,et al. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Caligiuri,et al. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. , 2001, Cancer research.
[33] E. Macintyre,et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease , 1999, Leukemia.
[34] H. Kaneko,et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. , 1996, Leukemia.